{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:10:19Z","timestamp":1793157019929,"version":"4.5.0"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T00:00:00Z","timestamp":1644451200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81771409"],"award-info":[{"award-number":["81771409"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>The limitations of adrenocorticotrophic hormone (ACTH) treatment for infantile spasms (ISs), such as high costs, limited availability, and adverse effects (AEs), make it necessary to explore whether corticosteroids are optimal alternatives. Many other compelling treatments have gone through trials due to the suboptimal effectiveness of hormonal therapy. A systematic review and meta-analysis were performed to evaluate the effectiveness and safety of hormonal therapy for patients with ISs.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>EMBASE, Ovid MEDLINE, Cochrane Central Register of Controlled Trials (CENTRAL), and online registers were searched through April 2021 for randomized controlled trials (RCTs).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 19 RCTs (<jats:italic>N<\/jats:italic> = 1,279) were included. There was no significant difference in the effectiveness of oral corticosteroids and ACTH in electro-clinical response (risk ratio [RR] = 0.85, 95% CI 0.41\u20131.76). Low-dose ACTH had similar effectiveness in electro-clinical response compared to usual-dose group (RR = 0.94, 95% CI 0.60\u20131.47) but conferred a lower risk of AEs (RR = 1.71, 95% CI 1.08\u20132.71). ACTH was more beneficial in controlling spasms than vigabatrin (VGB) (RR = 1.31, 95% CI 1.05\u20131.64) for patients without tuberous sclerosis complex (TSC). All RCTs were connected through network meta-analysis, and we found that ketogenic diet (KD), zonisamide, methylprednisolone, or combined treatment of hormonal therapy with topiramate (TPM) or pyridoxine was not different in electro-clinical response compared to usual-dose ACTH.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Our analysis showed that oral corticosteroids could be optional alternatives when ACTH is not applicable, and ACTH is more beneficial for patients without TSC. Moreover, low-dose ACTH is recommended due to comparative effectiveness but lower risk of AEs. However, due to the high heterogeneity of included patients and treatment protocols, these results must be interpreted with caution. RCTs with multicentric involvement and larger sample size are needed for solid evaluation of other alternative treatments.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fneur.2022.772333","type":"journal-article","created":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T10:20:29Z","timestamp":1644488429000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":22,"title":["Hormonal Therapy for Infantile Spasms: A Systematic Review and Meta-Analysis"],"prefix":"10.3389","volume":"13","author":[{"given":"Shiqi","family":"Guang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leilei","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linxiu","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangyun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zou","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,2,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/s13023-018-0952-x","article-title":"Latitudinal differences on the global epidemiology of infantile spasms: systematic review and meta-analysis","volume":"13","author":"Jia","year":"2018","journal-title":"Orphanet J Rare Dis."},{"key":"B2","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1177\/088307389100600412","article-title":"The epidemiology and natural history of infantile spasms","volume":"6","author":"Cowan","year":"1991","journal-title":"J Child Neurol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.pediatrneurol.2010.04.005","article-title":"Effect of price increase of adrenocorticotropic hormone on treatment practices of infantile spasms","volume":"43","author":"Wray","year":"2010","journal-title":"Pediatr Neurol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1001\/jamainternmed.2017.3631","article-title":"Trends and characteristics of US medicare spending on repository corticotropin","volume":"177","author":"Hartung","year":"2017","journal-title":"JAMA Intern Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/S0022-3476(83)80606-4","article-title":"Double-blind study of ACTH vs prednisone therapy in infantile spasms","volume":"103","author":"Hrachovy","year":"1983","journal-title":"J Pediatr."},{"key":"B6","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/S0022-3476(05)81379-4","article-title":"High-dose, long-duration versus low-dose, short-duration corticotropin therapy for infantile spasms","volume":"124","author":"Hrachovy","year":"1994","journal-title":"J Pediatr."},{"key":"B7","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1542\/peds.97.3.375","article-title":"High-dose corticotropin (ACTH) versus prednisone for infantile spasms: a prospective, randomized, blinded study","volume":"97","author":"Baram","year":"1996","journal-title":"Pediatrics."},{"key":"B8","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/S0387-7604(99)00053-4","article-title":"A comparative study of high-dose and low-dose ACTH therapy for West syndrome","volume":"21","author":"Yanagaki","year":"1999","journal-title":"Brain Develop"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1016\/S0140-6736(04)17400-X","article-title":"The United Kingdom Infantile Spasms Study comparing vigabatrin with prednisolone or tetracosactide at 14 days: a multicentre, randomised controlled trial","volume":"364","author":"Lux","year":"2004","journal-title":"Lancet (london, england)."},{"key":"B10","first-page":"445","article-title":"A comparative study of conventional dose and low dose adrenocorticotrophic hormone therapy for West syndrome","volume":"11","author":"Shu","year":"2009","journal-title":"Chin J Contemp Pediatr."},{"key":"B11","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.pediatrneurol.2015.05.004","article-title":"Randomized, single-blind, parallel clinical trial on efficacy of oral prednisolone versus intramuscular corticotropin on immediate and continued spasm control in west syndrome","volume":"53","author":"Wanigasinghe","year":"2015","journal-title":"Pediatr Neurol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s12098-018-2782-1","article-title":"Corticotrophin-ACTH in comparison to prednisolone in west syndrome\u2013a randomized study","volume":"86","author":"Gowda","year":"2019","journal-title":"Indian J Pediatr."},{"key":"B13","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"Bmj."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.17724\/jicna.2019.163","article-title":"Treatment of infantile spasms in resource limited settings: a randomized controlled trial","author":"Sardar","year":"2019","journal-title":"J Int Child Neurol Assoc."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1016\/j.eplepsyres.2014.06.019","article-title":"High dose (4 mg\/kg\/day) versus usual dose (2 mg\/kg\/day) oral prednisolone for treatment of infantile spasms: an open-label, randomized controlled trial","volume":"108","author":"Chellamuthu","year":"2014","journal-title":"Epilepsy Res."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/s12098-020-03630-3","article-title":"Intravenous methylprednisolone versus oral prednisolone for west syndrome: a randomized open-label trial","author":"Kapoor","year":"2021","journal-title":"Indian J Pediatr."},{"key":"B18","first-page":"113","article-title":"Vigabatrin versus ACTH as first line therapy in West syndrome","volume":"86","author":"Vigevano","year":"1994","journal-title":"Bollettino\u2013lega italiana contro l'epilessia"},{"key":"B19","first-page":"18","article-title":"Vigabatrin versus ACTH in the treatment of infantile spasms","volume":"7","author":"Omar","year":"2002","journal-title":"Neurosciences."},{"key":"B20","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1111\/epi.14679","article-title":"Efficacy and tolerability of the ketogenic diet versus high-dose adrenocorticotropic hormone for infantile spasms: a single-center parallel-cohort randomized controlled trial","volume":"60","author":"Dressler","year":"2019","journal-title":"Epilepsia."},{"key":"B21","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.ejpn.2018.09.006","article-title":"Safety, tolerability, and effectiveness of oral zonisamide therapy in comparison with intramuscular adrenocorticotropic hormone therapy in infants with West syndrome","volume":"23","author":"Angappan","year":"2019","journal-title":"Eur J Paediat Neurol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.clinthera.2010.04.008","article-title":"Three-week combination treatment with ACTH + magnesium sulfate versus ACTH monotherapy for infantile spasms: a 24-week, randomized, open-label, follow-up study in China","volume":"32","author":"Zou","year":"2010","journal-title":"Clin Therapeut."},{"key":"B23","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S1474-4422(16)30294-0","article-title":"Safety and effectiveness of hormonal treatment versus hormonal treatment with vigabatrin for infantile spasms (ICISS): a randomised, multicentre, open-label trial","volume":"16","author":"O'Callaghan","year":"2017","journal-title":"Lancet Neurol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"385","DOI":"10.4103\/0028-3886.227281","article-title":"Addition of pyridoxine to prednisolone in the treatment of infantile spasms: a pilot, randomized controlled trial","volume":"66","author":"Kunnanayaka","year":"2018","journal-title":"Neurol India."},{"key":"B25","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.seizure.2019.07.016","article-title":"High-dose prednisone therapy for infantile spasms and late-onset epileptic spasms in China: the addition of topiramate provides no benefit","volume":"71","author":"Yi","year":"2019","journal-title":"Seizure."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1111\/j.1528-1157.1997.tb00063.x","article-title":"Vigabatrin versus ACTH as first-line treatment for infantile spasms: a randomized, prospective study","volume":"38","author":"Vigevano","year":"1997","journal-title":"Epilepsia."},{"key":"B27","doi-asserted-by":"publisher","first-page":"CD001770","DOI":"10.1002\/14651858.CD001770.pub3","article-title":"Treatment of infantile spasms","volume":"6","author":"Hancock","year":"2013","journal-title":"Cochrane Datab System Rev."},{"key":"B28","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s12098-020-03521-7","article-title":"Safety, feasibility and effectiveness of pulse methylprednisolone therapy in comparison with intramuscular adrenocorticotropic hormone in children with west syndrome","volume":"88","author":"Rajpurohit","year":"2021","journal-title":"Indian J Pediatr."},{"key":"B29","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1177\/088307389901400201","article-title":"Vigabatrin in the treatment of infantile spasms in tuberous sclerosis: literature review","volume":"14","author":"Hancock","year":"1999","journal-title":"J Child Neurol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1177\/088307380001500304","article-title":"Vigabatrin as a first-choice drug in the treatment of West syndrome","volume":"15","author":"Fejerman","year":"2000","journal-title":"J Child Neurol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/dmcn.12573","article-title":"Does vigabatrin treatment for infantile spasms cause visual field defects? An international multicentre study","volume":"57","author":"Riikonen","year":"2015","journal-title":"Dev Med Child Neurol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.seizure.2021.07.017","article-title":"Efficacy, tolerability, and safety of zonisamide in children with epileptic spasms: a systematic review and meta-analysis","volume":"91","author":"Panda","year":"2021","journal-title":"Seizure."},{"key":"B33","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/ane.12830","article-title":"Efficacy of ketogenic diet for infantile spasms: a systematic review","volume":"137","author":"Prezioso","year":"2018","journal-title":"Acta Neurol Scand."},{"key":"B34","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1684\/epd.2021.1256","article-title":"Efficacy of the ketogenic diet on ACTH- or corticosteroid-resistant infantile spasm: a multicentre prospective control study","volume":"23","author":"Zhang","year":"2021","journal-title":"Epileptic Disord."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.772333\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T10:20:35Z","timestamp":1644488435000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.772333\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,10]]},"references-count":34,"alternative-id":["10.3389\/fneur.2022.772333"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2022.772333","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,10]]},"article-number":"772333"}}